hydantoins has been researched along with dihydrotestosterone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, Y; Beehler, BC; Fura, A; Golla, R; Grover, GJ; Hamann, LG; Huang, Y; Krystek, SR; Kuhns, JE; Lupisella, JA; Malley, MF; Ostrowski, J; Robl, JA; Sack, JS; Salvati, ME; Seethala, R; Sleph, PG; Sun, C; Wang, TC | 1 |
| Dong, Y; Guy, RK; Keiser, J; Lin, MF; Min, J; Muniyan, S; Vargas, M; Vennerstrom, JL; Wang, C; Wang, X; Zhao, Q | 1 |
2 other study(ies) available for hydantoins and dihydrotestosterone
| Article | Year |
|---|---|
Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffold.
Topics: Administration, Oral; Animals; Breast Neoplasms; Bridged-Ring Compounds; Cells, Cultured; Dihydrotestosterone; Humans; Hydantoins; Luciferases; Male; Mice; Muscle, Skeletal; Muscular Atrophy; Myoblasts; Rats; Receptors, Androgen; Transcriptional Activation | 2006 |
Antischistosomal versus antiandrogenic properties of aryl hydantoin Ro 13-3978.
Topics: Androgen Receptor Antagonists; Animals; Cell Line, Tumor; Cell Proliferation; Dihydrotestosterone; Disease Models, Animal; Humans; Hydantoins; Imidazolidines; Male; Mice; Schistosoma mansoni; Schistosomiasis mansoni; Schistosomicides | 2014 |